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Background: The purpose of this study is to report the use of activity-based cost analysis to 
identify areas of practice efficiencies and inefficiencies within a large academic retinal center 
and a small single-specialty group. This analysis establishes a framework for evaluating rapidly 
shifting clinical practices (anti-vascular endothelial growth factor therapy, microincisional 
vitrectomy surgery) and incorporating changing reimbursements for care delivery (intravitreal 
injections, optical coherence tomography [OCT]) to determine the impact on practice profit-
ability. Pro forma modeling targeted the impact of declining reimbursement for OCT imaging 
and intravitreal injection using a strategy that incorporates activity-based cost analysis into a 
direct evaluation schema for clinical operations management.
Methods: Activity-based costing analyses were performed at two different types of retinal 
practices in the US, ie, a small single-specialty group practice and an academic hospital-based 
practice (Bascom Palmer Eye Institute). Retrospective claims data were utilized to identify 
all procedures performed and billed, submitted charges, allowed charges, and net collections 
from each of these two practices for the calendar years 2005–2006 and 2007–2008. A pro forma 
analysis utilizing current reimbursement profiles was performed to determine the impact of 
altered reimbursement on practice profitability. All analyses were performed by a third party 
consulting firm.
Results: The small single-specialty group practice outperformed the academic hospital-based 
practice on almost all markers of efficiency. In the academic hospital-based practice, only four 
service lines were profitable, ie, nonlaser surgery, laser surgery, non-OCT diagnostics, and 
injections. Profit margin varied from 62% for nonlaser surgery to 1% for intravitreal injections. 
Largest negative profit contributions were associated with office visits and OCT imaging.
Conclusion: Activity-based cost analysis is a powerful tool to evaluate retinal practice 
  efficiencies. These two distinct practices were able to provide significant increases in clinical 
care (office visits, ophthalmic imaging, and patient procedures) through maintaining efficiencies 
of care. Pro forma analysis of 2011 data noted that OCT payments to facilities and physicians 
continue to decrease dramatically and that this payment decrease further reduced the profit-
ability for the two largest aspects of these retinal practices, ie, intravitreal injections and OCT 
retinal   imaging. Ultimately, all retinal practices are at risk for significant shifts in financial 
health related to rapidly evolving changes in patterns of care and reimbursement associated 
with providing outstanding clinical care.
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Introduction
Health care continues to remain a vital public health focus, 
with the emphasis on improving quality of care while reduc-
ing health care costs.1,2 This approach leads to a potential 
quandary for the practicing clinician because costs of care 
(new imaging technologies, expanding therapeutic armamen-
tariums) continue to increase, while reimbursements (optical 
coherence tomography [OCT] imaging, intravitreal injections) 
continue to decline.3 The ability of a practice or an individual 
physician to evaluate cost of care has not been a priority in 
typical medical practices.4 It seems clear that in this evolving 
environment of health care, that an understanding of how 
clinical practice patterns contribute to the cost of care for 
individual diseases and even individual patients may allow the 
clinician, and practice, to appropriate limited resources with 
the potential for greatest impact.5,6 Analysis of retinal practices 
have focused on improvements in productivity but have often 
neglected the hidden practice costs associated with increased 
care delivery. Additionally, multiple therapeutic strategies 
are now available to the retinal specialist, often without an 
understanding of the associated practice costs.
Previous financial evaluations of practice profitability 
have focused on revenue-based cost assignment. Revenue-
based cost assignment is limited by incorporation of an equal 
profit margin assumption that does not acknowledge differ-
ences within a practice associated with either above-average 
or below-average profitability of individual practitioners. 
Cooper and Kramer have argued that these “inaccuracies 
and distortions” in cost allocation are impact factors in the 
decision for higher-profit practitioners to depart the group 
practice.7–9 In Cooper and Kramer’s analysis, activity-based 
costing was utilized to allocate costs by individual activity 
directly, achieving an immediate shift in evaluation of prac-
tice profitability at the individual clinician level, as well as 
the practice level.7
This paper presents an established method of cost cal-
culation (activity-based costing) that is amenable to use in 
both physician-based and hospital-based retinal practices, 
irrespective of practice size. Activity-based costing is a cost 
calculation technique that associates costs with individual 
and grouped activities, known as cost centers.10,11 This 
technique enables an organization, or retinal practice, to 
determine actual costs of service on the basis of resources 
consumed.12,13 This accounting system has been applied to 
health care most recently in the evaluation of a large single-
specialty retinal practice.4 Activity-based costing provides 
the link between organizational revenue/expenses to enable 
a focus on efficiency/profitability.
Dugel and Tong utilized activity-based costing analysis 
to determine practice efficiencies and inefficiencies as they 
related to care of the patient with retinal disease within a 
  single-specialty practice.4 In this study, we apply activity-
based cost analysis to two common retinal practice environ-
ments, ie, the small single-specialty retinal group and the 
large academic retinal center. Finally, we use pro forma 
analysis of the determined data set to model the impact of 
changes in reimbursement on the practice’s profit margin.
Methods
Activity-based costing analyses were performed at three 
different types of retinal practices in the US, ie, a small 
single-specialty group practice, a large single-specialty 
group practice, and an academic hospital-based practice. 
All analyses were performed by a third party consulting firm 
(Quorum Consulting Inc, San Francisco, CA).
Due to unique differences in the operational structures 
of these practices, there was slight variation in the specific 
methodologies applied, but the general concept remained 
the same. Dugel and Tong provided the methodology for the 
study performed at the large single-specialty group practice, 
and here we describe the application of these methods in 
evaluating two unique study sites.4
Identification of primary activity centers
As in the study described by Dugel and Tong, we identified 
seven distinct revenue-generating activities for retinal phy-
sicians (hereafter referred to as service lines), ie, nonlaser 
surgery, laser surgery, evaluation and management (OCT), 
non-OCT diagnostics, intravitreal injections, and research.4 
Each service line was populated by the relevant group of 
Current Procedural Terminology (CPT) and Healthcare 
Common Procedure Coding System (HCPCS) codes for 
procedures that are described by the general service category. 
While research services were identified as a separate service 
line, we did not include it in any of our analyses because we 
chose to focus solely on the core retinal services that would 
be provided at both academic and nonacademic hospitals.
small single-specialty group practice
Data sources
The analysis was conducted at a two-physician retinal practice 
located in the Western US. We reviewed calendar year (CY) 
2005 and CY 2007 physician claims and expense reports for all 
retinal services performed in those timeframes. These claims 
were then analyzed to identify CPT and HCPCS codes billed, 
submitted charges, allowed charges, and net collections.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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revenue allocation methodologies
The physician claims billed by the two retinal physicians at 
this practice were analyzed to identify the revenues generated 
by each service line in both CY 2005 and CY 2007 based on 
the payment amounts collected for each relevant CPT and 
HCPCS code billed.
Cost allocation methodologies
The cost allocation methodologies that were applied to this 
practice mirror those employed at the large single-specialty 
group practice as described by Dugel and Tong. In order 
to assign practice costs across individual service lines in 
CY 2007 (the only year for which we were able to obtain 
detailed practice expense reports), physician salary expenses 
were allocated based on the distribution of relative value 
units for all CPT codes billed in that year, rental expenses 
were allocated according to the percentage of physician 
office space used per service line, and nonphysician staff 
salaries were allocated by the estimated time spent on each 
service line. Relative value units are used by the Centers 
for Medicare and Medicaid Services in the US as a metric 
for the extent of physician time and effort involved in each 
procedure reported by a CPT or HCPCS code. Therefore, in 
the absence of prospective measurements of physician time, 
we believed that a relative value units-based methodology 
would be appropriate to identify the distribution of physician 
time across the six service lines.
Academic hospital-based practice
Data sources
The analysis was conducted at a 100-bed ophthalmology 
specialty hospital affiliated with a tertiary academic center 
located in the Southeastern US. We reviewed fiscal year (FY) 
2006 and FY 2008 data from the hospital claims billing sys-
tems and general ledger to obtain information on the revenues 
and expenses for the hospital’s retinal practice. Both facility 
and physician claims were reviewed in this case.
Nine physicians common to both the facility and physi-
cian claims datasets in FY 2006 and FY 2008 were identified 
as full-time providers representative of retinal practice at the 
hospital. Using relative value units as a proxy for physician 
time based on the CPT codes billed by each physician, we 
were able to identify three distinct types of retinal service 
patterns that correspond to three physician subgroups: a 
“surgical” group focused mainly on surgical therapy (greater 
than 65% of relative value units allocated to the nonlaser and 
laser surgery service lines); a “medical” group that predomi-
nantly provided medical therapy (greater than 50% of relative 
value units allocated to injections); and a “mixed” group 
characterized by approximately equal provision of surgical 
and medical therapies. Specifically, we identified two physi-
cians in the surgical group, one in the medical group, and 
six in the mixed group. See Table 1 for each group’s overall 
distribution of relative value units across service lines.
revenue allocation methodologies
All hospital and physician claims billed by the nine retinal 
physicians were extracted, and the corresponding revenues 
assigned to one of the six core service lines based on the pay-
ment amounts collected for each relevant CPT and HCPCS 
code billed. This was done for claims in both FY 2006 and FY 
2008, with the resulting revenue allocations further broken 
down by the three physician subgroups.
Cost allocation methodologies
Physician expenses comprised salary and benefit costs. Esti-
mated annual salary figures in FY 2008 for each of the nine 
retinal physicians were provided by the academic center, and 
benefits were determined to represent an additional 39% of 
salary costs.
As discussed above, we decided to use a relative value units-
based methodology to estimate the distribution of physician 
time across service lines. We calculated the total relative value 
units associated with each service line (identified by groups of 
related CPT codes) for each physician and physician subgroup, 
thus providing an approximate distribution of time by which 
we allocated physician expenses in FY 2008. To determine the 
overall distribution of time for all physicians, the total relative 
value units associated with each service line was divided by 
the sum of the relative value units for all services.
Table 1 relative value unit distributions by retinal physician subgroup
Nonlaser  
surgery
Laser  
surgery
Office  
visits
OCT Non-OCT  
diagnostics
Injections
surgical 48% 22% 10% 3% 14% 3%
Mixed 34% 27% 19% 4% 3% 13%
Medical 0% 3% 25% 12% 2% 59%
Abbreviation: OCT, optical coherence tomography.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
916
Murray et al
The hospital provided FY 2008 expense reports for all 
113 departments, of which we identified 10 as direct cost 
contributors to the retinal practice, 75 as indirect cost con-
tributors, and the remaining 28 as zero cost contributors.
To determine the facility costs contributed to each service 
line by each indirect cost department, we first calculated 
the proportion of CPT/HCPCS units billed by the nine retinal 
physicians divided by the total number of units billed by all 
physicians who appeared in the entire hospital claims dataset 
for FY 2008 (which includes physicians who did not provide 
retinal services). This ratio was then multiplied by each 
indirect cost department’s reported total annual expenses to 
obtain the cost amount attributable to the retinal practice. The 
same methodology was used to delineate further the indirect 
costs associated with the surgical, medical, and mixed retinal 
physician subgroups, respectively.
To allocate direct facility costs, we employed two main 
methodologies that we refer to as “proxy” and “unit cost” 
allocations. For the proxy allocation, we consulted with the 
hospital’s accounting staff to identify several ratios that, 
where reasonable, could be applied to break out retinal-
related expenses from the overall costs reported by direct 
cost departments. These ratios or proxies include:
•	 Retinal service charges to total hospital charges
•	 Retinal inpatient charges to total hospital inpatient 
charges
•	 Retinal service square footage to total hospital square 
footage
•	 Number of retinal patient visits to total number of hospital 
patient visits
•	 Number of retinal surgery cases to total number of 
  hospital surgery cases
In some cases, estimates were provided directly by the 
department manager instead (eg, 15% of expenses incurred 
by the physician logistics department may be attributable to 
retinal services).
After using one of these proxies to identify the retinal-
related portion of a direct cost department’s overall expenses, 
retinal practice expenses were then allocated across service 
lines based on the distribution of the number of CPT/HCPCS 
units billed on hospital claims in FY 2008 (since each CPT/
HCPCS code is assigned to a specific service line).
When retinal-related expenses for a particular depart-
ment could not be broken out from the total department 
costs by applying a proxy allocation, we used a “unit cost” 
approach to determine the amount attributable to each reti-
nal service line. To do so, we first calculated the number of 
staff hours worked per “service unit” within each service 
line based on the staff time data provided by the hospital 
for each   department. For each service line, the proportion 
of this figure to the total number of staff hours worked by 
the department was then multiplied by the total expenses 
incurred by that department to arrive at the per unit cost. 
Therefore, where applicable, the retinal-related departmental 
expenses associated with each service line is the sum of 
the per unit cost multiplied by the corresponding number 
of service units billed on hospital claims in FY 2008. See 
Table 2 for a summary of the expense allocation schemes 
applied to each of the 10 hospital departments contributing 
direct costs to the retinal practice.
Pro forma estimate of impact of changes 
in Medicare payment rates in 2011
Much has been written about changes in CPT coding and 
Medicare reimbursement rates for ophthalmology services. In 
particular, three new CPT codes were issued effective 2011 
for OCT procedures replacing CPT code 92135. The great-
est impact on revenues of these new codes is in the fact that 
they now represent unilateral or bilateral procedures, whereas 
previously OCT was a unilateral procedure that could be 
billed and reimbursed twice for the same patient during the 
same encounter. Given these recent changes, we also mod-
eled the revenue and profitability implications of Medicare 
reimbursement rates in 2011, assuming the same volume of 
services and no changes in commercial payment.
Results
small single-specialty group practice
Between CY 2005 and CY 2007, total procedure volume 
at this practice (as indicated by the number of CPT units 
billed in each year) increased by a modest 24%. However, 
within individual service lines, injections saw the most 
  dramatic increase of 236%, with the exception of laser 
surgery, which actually decreased by 53%, the volume of 
all other service lines (nonlaser surgery, office visits, OCT, 
non-OCT diagnostics) increased by 0%–40%, (Figure 1).
Aligned with these trends in procedure volume changes 
between CY 2005 and CY 2007, the largest percentage increase 
in revenue was observed for injections (304%), while OCT was 
a distant second with a 79% increase in the same timeframe. 
Of the four remaining service lines, except for office visits, 
all saw less revenue in CY 2007 compared with CY 2005. We 
also observed a 7% increase in reimbursements received for 
drugs as a standalone revenue source (Figure 2).
Based on practice expense reports obtained for CY 
2007, the majority of practice costs were attributed to office Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 2 expense allocation schemes for direct cost departments
Hospital department Retinal-related cost 
allocation scheme1
Service line cost 
allocation scheme2
surgery number of retinal surgery cases to total  
number of hospital surgery cases
Distribution of hospital (CPT/hCPCs) units billed  
across nonlaser and laser surgery service lines
Ambulatory surgery hospital staff estimate none – 100% of retinal-related costs attributable  
to nonlaser surgery
Anesthesiology number of retinal surgery cases to total  
number of hospital surgery cases
Distribution of hospital (CPT/hCPCs) units billed  
between nonlaser and laser surgery
recovery room number of retinal surgery cases to total  
number of hospital surgery cases
Distribution of hospital (CPT/hCPCs) units billed  
between nonlaser and laser surgery
Outpatient nursing “Unit cost” allocation “Unit cost” allocation
retina clinic none – 100% of department expenses  
attributable to retinal practice
none – 100% of retinal-related costs  
attributable to e&M
Photography hospital staff estimate “Unit cost” allocation
echography hospital staff estimate “Unit cost” allocation
Pharmacy “Unit cost” allocation “Unit cost” allocation
Physician logistics hospital staff estimate Distribution of hospital (CPT/hCPCs) units billed  
across all service lines
Notes: 1Identifies the allocation scheme used to carve out retinal-related cost from total departmental expenses; 2Identifies the allocation scheme used to distribute retinal-
related cost across relevant service lines. 
Abbreviations: e&M, evaluation and management; CPT, Current Procedural Terminology; hCPCs, healthcare Common Procedure Coding system.
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Figure 1 small single-specialty group practice: percent change in procedure volume.
Abbreviation: OCT, optical coherence tomography.
visits (33%), followed by injections (17%) and non-OCT 
diagnostics (17%). Alternatively, when analyzing the spe-
cific cost centers that constitute practice expenses, salaries 
and benefits contributed a 66% majority, followed by rent 
and utilities (12%) and drug acquisition costs (11%). See 
Figures 3A and 3B for the detailed cost breakdowns by 
individual service lines and cost centers, respectively.
Overall, with the exception of office visits, all service 
lines were profitable at this small retinal group practice in 
CY 2007. Profit margin (profit divided by revenue) is an 
economic measure of how efficiently revenue is converted 
into profit, or in this case, how efficiently costs are controlled 
for a particular service line. At this practice, nonlaser surgery 
demonstrated the highest profit margin at 39%, whereas office 
visits had the lowest at -2%. All other service lines (laser 
surgery, OCT, non-OCT diagnostics, and injections) had 
profit margins in the range of 16%–37% (Figure 4).
Academic hospital-based practice
Between FY 2006 and FY 2008, all service lines grew in 
terms of procedure volume, and injections and OCT saw the 
most significant increases of 106% and 105%, respectively, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 2 small single-specialty group practice: percent change in revenue.
Abbreviation: OCT, optical coherence tomography.
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Figure 3B small single-specialty group practice: distribution of costs by cost center.
while laser surgery increased by the smallest margin of 2% 
(Figure 5).
These results were generally mirrored in the growth 
trends in revenue observed in this timeframe. In this section, 
revenues refer to the aggregate payments received for both 
facility and physician claims billed. Due to the significant 
increase in intravitreal injections performed, drug revenue at 
this practice saw a dramatic increase of 387% that was largely 
driven by rising collections for ranibizumab.   Following 
drugs, revenues for OCT and injections experienced growth 
of 111% and 79%, respectively (Figure 6A).
We also analyzed overall changes in revenue for each 
retinal physician subgroup, and subsequently observed 
the largest percentage increase in total revenue for the 
medical group (116%) when collections for drugs were 
taken into account, followed by the mixed (56%) and 
surgical (26%) groups. This finding is not surprising in 
light of the significant revenue contributions provided by 
the highly reimbursed drugs used for intravitreal injections. 
However, when drug collections were excluded from the 
revenue analysis, the mixed group offered the largest per-
centage increase in total revenue (42%), whereas the medical 
group saw the smallest growth (16%). See Figure 6B for 
an overview of revenue changes for each retinal physician 
subgroup.
Total expenses incurred at this academic hospital-based 
practice include both facility (eg, medical supplies, operat-
ing room overheads) and physician costs (physician salaries, 
benefits). The majority of total practice expenses in FY 2008 
were contributed by injections (28%), with office visits a close 
second (25%). Laser surgery represented the lowest-cost ser-
vice line, constituting 4% of total expenses (Figure 7A).
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Figure 3A small single-specialty group practice: distribution of costs by service line.
Abbreviation: OCT, optical coherence tomography.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
919
Cost analysis in retinal practice
28%
26%
37%
16%
39%
−2%
10%
0%
−10%
20%
30%
40%
50%
Nonlaser
surgery
Laser surgery Non-OCT
diagnostics
Injections
P
r
o
f
i
t
 
m
a
r
g
i
n
Office visits OCT
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Figure 5 Academic hospital-based practice: percent change in procedure volume.
Abbreviation: OCT, optical coherence tomography.
When evaluating the distribution of costs for each retinal 
physician subgroup, office visits were the majority cost con-
tributor in both the surgical and mixed groups, with shares of 
23% and 30%, respectively (for the surgical group, however, 
non-OCT diagnostics also tied with office visits to represent 
23% of total costs). In contrast, injections constituted the 
highest percentage of total costs in the medical group by far 
at 61% (Figure 7B).
Overall, only four service lines, ie, nonlaser surgery, 
laser surgery, non-OCT diagnostics, and injections, were 
  profitable at this academic hospital-based practice in FY 
2008; losses were incurred in both office visits and OCT. 
A profit margin analysis identified nonlaser surgery as the 
service line with the highest profit margin (62%), followed 
by laser surgery (51%) and non-OCT diagnostics (22%),   
see Figure 8.   Injections, the only other profitable service line, 
demonstrated a very low profit margin of 1%. In line with the 
negative profit contributions associated with office visits and 
OCT, both of these service lines were found to have profit 
efficiencies of -100% or less.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
920
Murray et al
15% 23%
111%
30%
79%
387%
0%
100%
−100%
0%
200%
300%
400%
500%
Nonlaser
surgery
Laser
surgery
Non-OCT
diagnostics
Drugs
P
e
r
c
e
n
t
 
c
h
a
n
g
e
 
i
n
 
r
e
v
e
n
u
e
Office visits OCT Injections
Figure 6A Academic hospital-based practice: percent change in revenue.
Abbreviation: OCT, optical coherence tomography.
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Figure 9 Medicare national physician payment for bilateral OCT and intravitreal 
injections between 2010 and 2011.
Abbreviation: OCT, optical coherence tomography.
Pro forma estimate of the impact of 
changes in Medicare payment rates in 2011
There were several changes in Medicare reimbursement 
rates that affected retinal providers which became effective 
in January 2011. Each year, the Centers for Medicare and 
Medicaid Services adjusts hospital (facility) reimbursement 
rates under the Outpatient Prospective Payment System. 
These rates have typically gone up across the board, given 
higher labor and other costs incurred by hospital facilities.
However, physician professional fees can vary year to year 
based on a myriad of inputs including: changes to   relative 
value units, often performed every five years as part of rou-
tine updates; changes in the conversion factor, which has 
been a political “football” given controversies surrounding 
the sustainable growth rate; and changes in CPT coding and 
other limitations, which may affect rules surrounding when 
procedures may be billed during the same patient encoun-
ter. One of the biggest changes in ophthalmology, effective 
January 1, 2011, was that the single OCT CPT code was 
withdrawn in 2011 and replaced by three separate codes, one 
each for the optic nerve, retina, and anterior   segment. More 
importantly, the new OCT codes were written to include the 
phrase “unilateral or bilateral”, resulting in a single payment 
regardless of whether the OCT was performed unilaterally 
or bilaterally. Hence, while the Centers for Medicare and 
Medicaid Services payment levels for the new codes are 
similar to what was previously paid for CPT 92135, the new 
codes have effectively reduced reimbursements by about 
50% if patients are imaged bilaterally (https://www.cms.gov/
MLNProducts/65_ophthalmology.asp), see Figure 9.
Figure 10 indicates the impact on Medicare revenues and 
hospital profits when adjusting for 2011 Medicare payment 
rates. Non-Medicare payments, volume of services, and 
expenses were held constant based on 2008 data. While hospital 
facility rates have increased slightly, changes to OCT coding 
show the greatest negative impact. Furthermore, across the three 
different practice types, medical practices were most impacted 
(negatively) compared with surgical and mixed practices (see 
Figures 11A–11C, 12A–12C and 13A–13C). As expected, 
contribution to profit also changed, shifting away from OCT.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
922
Murray et al
80%
60%
40%
20%
−20%
−40%
−60%
−50%
−45%
−2%
0%
14% 11%
1% 1%
67%
5%
19%
9%
22%
11%
2%
Physician
Hospital
Nonlaser
surgery
Laser surgery Injections Non-OCT
diagnostics
OCT
(unilateral)
OCT
(bilateral)
Office visits
Figure 10 Average change in Medicare reimbursement between 2008 and 2011 across service lines.
Abbreviation: OCT, optical coherence tomography.
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Figure 11A Mixed practice: 2008 distribution of revenue by service line.
Abbreviation: OCT, optical coherence tomography.
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Figure 11B Mixed practice: 2011 distribution of revenue by service line (assuming 
OCT procedures are performed bilaterally).
Abbreviation: OCT, optical coherence tomography.
Discussion
Ophthalmology in general, and retinal in particular, have 
seen tumultuous changes in practice patterns over the last 
five years. Most significantly, advances in diagnostic imag-
ing (OCT), intravitreal pharmacotherapy (bevacizumab/
ranibizumab/triamcinolone acetonide) and vitreoretinal 
surgery (microincisional vitrectomy surgery) have fun-
damentally changed the practice patterns of most retinal 
specialists.14 These changes have had a profound impact 
on clinical volumes (increasing follow-up intervals for 
many disease processes from every six months to every 
four weeks), treatment paradigms (shifting from laser/
observation to intravitreal injection), and diagnostic 
evaluations (moving from fluorescein angiography to OCT 
imaging) that have required increasing practice overheads 
by expanding clinical space, front and back office billing, 
and administrative personnel, and increased technology 
(OCT units) and specialized nursing care (intravitreal 
injections).15–19
Evaluating the impact of this changing clinical environ-
ment is difficult and has been beyond the purview of most 
clinicians.20,21 Advances in health care economic practices 
have utilized various instruments to determine the impact of 
clinical patient care on practice profitability.22–24 Previously, 
activity-based costing was used by Dugel and Tong to assess 
the impact of these changes on a large single-specialty reti-
nal practice. In this study, the authors noted an increase in Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Figure 11C Mixed practice: change in total revenue between 2008 and 2011.
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Figure 12A surgical practice: 2008 distribution of revenue by service line.
Abbreviation: OCT, optical coherence tomography.
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Figure 12B surgical practice: 2011 Distribution of revenue by service line (Assuming 
OCT procedures are performed bilaterally).
Abbreviation: OCT, optical coherence tomography.
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Figure 12C surgical practice: change in total revenue between 2008 and 2011.
Abbreviation: OCT, optical coherence tomography.
practice collections of over 42% during the study interval 
which, due to increases in operating costs and decreasing 
reimbursement, led the practice to an overall decline in 
profit margin by 14%.4 Activity-based costing allows for 
specific evaluation of service line impacts on overall prac-
tice profitability, but is also targeted to evaluate the actual 
and modeled impact of changes in each practice procedure 
(ie, increasing frequency of intravitreal injections versus 
decreasing frequency, decreasing reimbursement for OCT, 
impact of novel therapy such as vascular endothelial growth 
factor trap (including treatment cost, treatment interval, and 
imaging analysis).
Pro forma modeling, utilizing activity-based costing, 
allows the practice to determine the impact of changes in 
clinical care provision, “overhead” operating costs, and 
reimbursement. There were significant changes in reimburse-
ment for 2011, “highlighted” by reduced reimbursements for 
intravitreal injection (67028) and posterior segment OCT 
imaging (92135 to 92133/4). Reimbursement for intravitreal 
injections showed a decline from approximately $159 in 
2010 to $107 in 2011. The coding change for OCT imaging 
from a unilateral code (92135) in 2010 to “unilateral OR 
bilateral” codes (92133/4) in 2011 means that reimbursement 
for bilateral OCT imaging is essentially halved because the 
reimbursement rate is now the same regardless of whether 
the procedure is performed on one or both eyes. The recent 
devaluations in many ways portend the future for retinal 
specialists. Particular targets for revaluation of reimburse-
ment include rapidly evolving usage which, for intravitreal 
injection, went from approximately 4000 procedures in 2000 
to approximately 1,000,000 in 2010. OCT imaging skyrock-
eted during a similar period, with approximately 150,000 
procedures in 2000 to over 8,000,000 procedures in 2008. 
Based on our analysis of the 2003–2009   Physician/Supplier 
Procedure Summary for CPT codes 67028 (intravitreal 
injection) and 92135 (OCT), the Centers for Medicare and 
Medicaid Services allowed units increased from 38,799 in 
2003 to 1,297,524 in 2009 for intravitreal injections, while 
for OCT imaging Centers for Medicare and Medicaid 
  Services allowed units increased from 2,163,115 in 2003 to 
7,687,443 in 2009.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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injections, increasing operating overheads (office space, 
support staff, coding/billing), and declining retinal practice 
profitability. Uniquely, we did not see regional influences 
on practice patterns and reimbursement that could poten-
tially have skewed the data analysis. Finally, although we 
accounted for salary and benefits within our activity-based 
costing analysis, we did not incorporate nonclinical revenue 
sources that are ubiquitously present in current academic 
retinal and community-based retinal   practices. These sup-
port dollars often negate significant clinical losses to enable 
overall profitability of an academic department. These 
  dollars are outside of the impact of clinical care delivery and 
reimbursement. Nonetheless, these limitations are critically 
important in the extrapolation of these data widely within 
the retinal community.
In ophthalmological retinal care practices, the major clini-
cal focus has been provision of outstanding patient-focused 
clinical care. Cost issues in care provision have been largely 
ignored in the decision-making for patient care in this evolv-
ing environment. This focus on best patient care continues 
to be a hallmark of retinal care delivery. Nonetheless, an 
understanding of the potential and real impact of changes in 
practice costs and reimbursements is critical to the economic 
survival of our best academic and clinical practices.   Evolving 
efficiencies in clinical practice will continue to push the 
ophthalmologist’s approach to declining reimbursement and 
increasing practice costs. Unique approaches to care delivery 
have recently been employed and have come under targeted 
scrutiny, most notably pharmaceutical-based rebate programs 
in the management of neovascular AMD (http://www.aao.
org/newsroom/release/20101223.cfm). Rebate programs 
of this nature were not included in the pro forma analysis, 
but have major practice reimbursement impact. Ultimately, 
alternative strategies for reimbursement may be necessary 
as treatment costs escalate in the face of expanding at-risk 
patient populations.
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Figure 13A Medical practice: 2008 distribution of revenue by service line.
Abbreviation: OCT, optical coherence tomography.
59%
5%
6%
0%
12% 18% Nonlaser 
surgery
Laser surgery
Office visits
OCT
Non-OCT 
diagnostics
Injections
Figure 13B Medical practice: 2011 distribution of revenue by service line (assuming 
OCT procedures are performed bilaterally).
Abbreviation: OCT, optical coherence tomography.
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Figure 13C Medical practice: change in total revenue between 2008 and 2011.
Limitations to this study focus on the choice of both a 
single academic retinal service (Bascom Palmer Eye Insti-
tute, University of Miami Miller School of Medicine) and 
a small, community-based retinal practice (Tornambe Eye 
Institute). We chose these two practices to delineate better 
the breadth of retinal clinical practice approaches to estab-
lish the viability of activity-based cost analysis (to establish 
financial parameters) and to evaluate efficiencies of care. 
Activity-based costing analysis was previously applied by 
Dugel and Tong to evaluate a large, community-based retinal 
practice. In all three settings, varied efficiencies of each 
practice were established, but overall analysis established 
several defining practice patterns, ie, increasing clinical 
volumes, decreasing reimbursement for OCT and intravitreal   Clinical Ophthalmology
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Conclusion
In this study, assessing a critical window of change in the retinal 
field, a large academic hospital-based retinal center and a small 
single-specialty retinal group were evaluated with activity-
based cost analysis to establish the impact of these changing 
clinical environments on the economic health of these practices. 
The understanding of the interface between cost of care and 
its impact on clinical decision-making is likely to become a 
pivotal point in the retinal specialist’s ability to navigate rapidly 
changing health care policy during this decade.
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